Abiopharma

New Form 424B4 - Longeveron Inc. Filed: 2025-08-11 AccNo: 0001213900-25-073922 Size: 353 KB

New Form 8-K - DuPont de Nemours, Inc. Filed: 2025-08-11 AccNo: 0001193125-25-177454 Size: 166 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Charlie's Holdings, Inc. Filed: 2025-08-11 AccNo: 0001437749-25-025812 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

Agenus Inc. - Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

New Form 10-Q - Immunovant, Inc. Filed: 2025-08-11 AccNo: 0001764013-25-000129 Size: 4 MB

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress

New Form 8-K - LIGAND PHARMACEUTICALS INC Filed: 2025-08-11 AccNo: 0001193125-25-177452 Size: 489 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Roivant Sciences Ltd. Filed: 2025-08-11 AccNo: 0001140361-25-029998 Size: 383 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Apogee Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106228 Size: 518 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Immunovant, Inc. Filed: 2025-08-11 AccNo: 0001764013-25-000128 Size: 247 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

DUPONT DE NEMOURS, INC. AND QNITY ELECTRONICS, INC. ANNOUNCE OFFERING OF SENIOR SECURED NOTES AND SENIOR NOTES

Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025

New Form ARS - Lantern Pharma Inc. Filed: 2025-08-11 AccNo: 0001641172-25-022896 Size: 2 MB

New Form 8-K - BIOCRYST PHARMACEUTICALS INC Filed: 2025-08-11 AccNo: 0001171843-25-005265 Size: 187 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers